Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CYTX > SEC Filings for CYTX > Form 8-K on 11-Aug-2014All Recent SEC Filings

Show all filings for CYTORI THERAPEUTICS, INC.

Form 8-K for CYTORI THERAPEUTICS, INC.


11-Aug-2014

Results of Operations and Financial Condition, Change in Directors or P


Item 2.02 Results of Operations and Financial Condition

On August 11, 2014 Cytori Therapeutics, Inc. (Company) issued a press release announcing its financial results for the first quarter ended June 30, 2014. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information disclosed under this Item 2.02 in this report, including Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 5, 2014, Mark E. Saad, the Company's Chief Financial Officer, resigned from the position of Chief Financial Officer effective August 11, 2014. Mr. Saad will remain as a consultant for the Company and will continue to support the management team during a transition period. The Board of Directors has appointed Dr. Marc Hedrick, Cytori's President and Chief Executive Officer, to serve as Principal Financial Officer until such time as the Company appoints a new Chief Financial Officer.

The Company issued a press release including announcement of the senior management change. A copy of the press release is attached hereto as Exhibit
99.1. Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.

Item 9.01           Financial Statements and Exhibits

(d)      Exhibits

Exhibit No.    Description
99.1           Cytori Therapeutics, Inc. Press Release, dated August 11, 2014 *

* Exhibit 99.1 hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.


  Add CYTX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CYTX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.